- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1934
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Intranasal Insulin for Alzheimer’s Disease ; volume:35 ; number:1 ; day:30 ; month:1 ; year:2021 ; pages:21-37 ; date:1.2021
CNS drugs ; 35, Heft 1 (30.1.2021), 21-37, 1.2021
- Creator
-
Hallschmid, Manfred
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40263-020-00781-x
- URN
-
urn:nbn:de:101:1-2021042121031076814359
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hallschmid, Manfred
- SpringerLink (Online service)
Other Objects (12)
Diabetes, insulin and Alzheimer's disease
Impairment of insulin signaling pathway in Alzheimer’s disease
Impairment of insulin signaling pathway in Alzheimer’s disease
Alzheimer’s Disease
Photoaffinity Probes for Alzheimer’s Disease
Blood biomarkers for Alzheimer’s disease
Neuroimaging Biomarkers for Alzheimer’s Disease
Alzheimer's disease
Active immunotherapy options for Alzheimer’s disease
Urinary metabolic phenotyping for Alzheimer’s disease
Intranasal Insulin Reduces White Matter Hyperintensity Progression in Association with Improvements in Cognition and CSF Biomarker Profiles in Mild Cognitive Impairment and Alzheimer’s Disease
Insulin-Like Growth Factor Signaling in Alzheimer’s Disease: Pathophysiology and Therapeutic Strategies
Diabetes, insulin and Alzheimer's disease
Impairment of insulin signaling pathway in Alzheimer’s disease
Impairment of insulin signaling pathway in Alzheimer’s disease
Alzheimer’s Disease
Photoaffinity Probes for Alzheimer’s Disease
Blood biomarkers for Alzheimer’s disease
Neuroimaging Biomarkers for Alzheimer’s Disease
Alzheimer's disease
Active immunotherapy options for Alzheimer’s disease
Urinary metabolic phenotyping for Alzheimer’s disease
Intranasal Insulin Reduces White Matter Hyperintensity Progression in Association with Improvements in Cognition and CSF Biomarker Profiles in Mild Cognitive Impairment and Alzheimer’s Disease
Insulin-Like Growth Factor Signaling in Alzheimer’s Disease: Pathophysiology and Therapeutic Strategies
Diabetes, insulin and Alzheimer's disease
Impairment of insulin signaling pathway in Alzheimer’s disease
Impairment of insulin signaling pathway in Alzheimer’s disease
Alzheimer’s Disease
Photoaffinity Probes for Alzheimer’s Disease
Blood biomarkers for Alzheimer’s disease
Neuroimaging Biomarkers for Alzheimer’s Disease
Alzheimer's disease
Active immunotherapy options for Alzheimer’s disease
Urinary metabolic phenotyping for Alzheimer’s disease
Intranasal Insulin Reduces White Matter Hyperintensity Progression in Association with Improvements in Cognition and CSF Biomarker Profiles in Mild Cognitive Impairment and Alzheimer’s Disease